Paola Caruso

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

BMPR2 Mutation and Metabolic Reprogramming in Pulmonary Arterial Hypertension.

BMPR2 Mutation and Metabolic Reprogramming in Pulmonary Arterial Hypertension.

Journal: Circulation research
Published: January 05, 2023

Author Correction: Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.

Author Correction: Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.

Journal: Communications biology
Published: January 21, 2022

MIR503HG Loss Promotes Endothelial-to-Mesenchymal Transition in Vascular Disease.

MIR503HG Loss Promotes Endothelial-to-Mesenchymal Transition in Vascular Disease.

Journal: Circulation research
Published: March 11, 2021

Circulating BMP9 Protects the Pulmonary Endothelium during Inflammation-induced Lung Injury in Mice.

Circulating BMP9 Protects the Pulmonary Endothelium during Inflammation-induced Lung Injury in Mice.

Journal: American journal of respiratory and critical care medicine
Published: December 15, 2020

Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.

Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.

Journal: Communications biology
Published: August 26, 2020

Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2.

Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2.

Journal: Circulation
Published: February 28, 2017

Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.

Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.

Journal: Circulation
Published: February 24, 2017

Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA/programmed cell death 4/caspase-3 axis.

Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA/programmed cell death 4/caspase-3 axis.

Journal: Hypertension (Dallas, Tex. : 1979)
Published: April 16, 2014

Proteomic analysis implicates translationally controlled tumor protein as a novel mediator of occlusive vascular remodeling in pulmonary arterial hypertension.

Proteomic analysis implicates translationally controlled tumor protein as a novel mediator of occlusive vascular remodeling in pulmonary arterial hypertension.

Journal: Circulation
Published: March 25, 2014

Transcript analysis reveals a specific HOX signature associated with positional identity of human endothelial cells.

Transcript analysis reveals a specific HOX signature associated with positional identity of human endothelial cells.

Journal: PloS one
Published: October 01, 2013

A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples.

A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples.

Journal: Circulation research
Published: June 21, 2012

Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension.

Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 25, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026